Clincosm LogoSign in Get a demo

Carcinoma, Non-small Cell Lung

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Non-Small Cell Lung Trial in Zhengzhou (BAI combine with DEB-BACE)

Not yet recruiting
  • Carcinoma, Non-Small Cell Lung
  • BAI combine with DEB-BACE
  • Zhengzhou, Henan, China
    Gang Wu
Nov 7, 2023

KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small Cell Lung, NSCLC Trial (JDQ443, trametinib, Ribociclib)

Recruiting
  • KRAS G12C Mutant Solid Tumors
  • +10 more
  • Boston, Massachusetts
  • +5 more
Jan 11, 2023

Atezolizumab in Ministry of Food and Drug Safety-Approved

Completed
  • Urothelial Carcinoma
  • +4 more
  • Busan, Korea, Republic of
  • +55 more
Aug 23, 2022

Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung Trial in United States (Entinostat, Placebo, Erlotinib)

Completed
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Carcinoma, Non-Small Cell Lung
  • Tucson, Arizona
  • +29 more
Aug 18, 2022

Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Tumors, Ovarian Tumors Trial in Worldwide (SGN-STNV)

Recruiting
  • Carcinoma, Non-Small Cell Lung
  • +11 more
  • Los Angeles, California
  • +16 more
Aug 15, 2022

Carcinoma, Non-Small Cell Lung Trial in Washington, Baltimore (Durvalumab)

Recruiting
  • Carcinoma, Non-Small Cell Lung
  • Washington, District of Columbia
  • +2 more
Jun 10, 2022

Carcinoma, Non-Small Cell Lung Trial (sequential DEB-BACE and Arotinib and Tirelizumab, DEB-BACE alone)

Not yet recruiting
  • Carcinoma, Non-Small Cell Lung
  • sequential DEB-BACE and Arotinib and Tirelizumab
  • DEB-BACE alone
  • (no location specified)
May 14, 2022

Carcinoma, Non-small Cell Lung Trial in Changsha (ethaselen)

Completed
  • Carcinoma, Non-small Cell Lung
  • Changsha, Hunan, China
    Hunan province tumor hospital
Mar 1, 2022

Carcinoma, Non-Small Cell Lung, EGFR Gene Mutation Trial in Changsha (Gemcitabine platinum combined with erlotinib)

Recruiting
  • Carcinoma, Non-Small Cell Lung
  • EGFR Gene Mutation
  • Gemcitabine platinum combined with erlotinib
  • Changsha, Hunan, China
    Hunan Province Tumor Hospital
Feb 28, 2022

Carcinoma, Non-Small Cell Lung Trial in Netherlands (carboplatin, paclitaxel, Bevacizumab)

Active, not recruiting
  • Carcinoma, Non-Small Cell Lung
  • Amsterdam, Noord-Holland, Netherlands
  • +27 more
Dec 6, 2021

Carcinoma, Non-Small Cell Lung, NSCLC, Non-Small-Cell Lung Carcinoma Trial (Capmatinib)

Available
  • Carcinoma, Non-Small Cell Lung
  • +3 more
  • (no location specified)
Aug 31, 2021

Lung Cancer, Carcinoma, Non-Small Cell Lung Trial in Omaha (consolidative hypofractionated radiation therapy (hfRT), Durvalumab

Recruiting
  • Lung Cancer
  • Carcinoma, Non-Small Cell Lung
  • consolidative hypofractionated radiation therapy (hfRT)
  • Durvalumab 50 MG/ML
  • Omaha, Nebraska
    University of Nebraska Medical Center
Jul 27, 2021

Carcinoma, Non-Small Cell Lung Trial (Atezolizumab, Placebo, Carboplatin)

Withdrawn
  • Carcinoma, Non-Small Cell Lung
  • (no location specified)
Jun 14, 2021

Cancer of Lung, Cancer of the Lung, Lung Cancer Trial in United States (Microwave Ablation)

Terminated
Has Results
  • Cancer of Lung
  • +6 more
  • Microwave Ablation
  • Duarte, California
  • +4 more
Dec 18, 2020

Carcinoma, Non-small Cell Lung Trial in Spain, United States (Abemaciclib, Pemetrexed, Gemcitabine)

Completed
Has Results
  • Carcinoma, Non-small Cell Lung
  • Fayetteville, Arkansas
  • +10 more
Aug 22, 2020

Carcinoma, Non-Small Cell Lung, NSCLC, Nonsmall Cell Lung Cancer Trial in Saint Louis (Pazopanib)

Terminated
Has Results
  • Carcinoma, Non-Small Cell Lung
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 13, 2020

Cancer of the Lung, Lung Cancer, Tumors, Lung Trial in United States (Microwave ablation)

Withdrawn
  • Cancer of the Lung
  • +5 more
  • Microwave ablation
  • Duarte, California
  • +4 more
May 29, 2020

Carcinoma, Non-small Cell Lung Trial in Changsha (Aprepitant, )

Completed
  • Carcinoma, Non-small Cell Lung
  • Changsha, Hunan, China
    Hunan Cancer hospital
Mar 25, 2020

Carcinoma, Non-Small Cell Lung, Adenocarcinoma, Carcinoma, Squamous Cell Trial run by the NCI (PF-02341066/PF-00299804)

Terminated
  • Carcinoma, Non-Small Cell Lung
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Carcinoma, Non-small Cell Lung Trial (EFG816, erlotinib or gefitinib)

Withdrawn
  • Carcinoma, Non-small Cell Lung
  • (no location specified)
Nov 21, 2019

Carcinoma, Non-Small Cell Lung Trial in Beijing (Sintilimab)

Recruiting
  • Carcinoma, Non-Small Cell Lung
  • Beijing, Beijing, China
    Department of Respiratory Medicine, Peking Union Medical College
Nov 15, 2019

Genotypes in Adults Undergoing Therapy for Lung Cancer

Completed
  • Carcinoma, Non-Small Cell Lung
  • Carcinoma, Small-Cell Lung
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 8, 2019

    Tumors, Melanoma, Colorectal Tumor Trial in United States (ASN003 ascending doses, ASN003 MTD)

    Terminated
    • Neoplasms
    • +3 more
    • ASN003 ascending doses
    • ASN003 MTD
    • Los Angeles, California
    • +4 more
    May 17, 2019

    Carcinoma, Non-small Cell Lung Trial in Netherlands (Docetaxel, Erlotinib)

    Terminated
    • Carcinoma, Non-small Cell Lung
    • Amsterdam, Noord-Holland, Netherlands
    • +18 more
    Apr 26, 2019

    Carcinoma, Non-Small Cell Lung Trial in Jinan (Consolidation Sintilimab)

    Unknown status
    • Carcinoma, Non-Small Cell Lung
    • Consolidation Sintilimab
    • Jinan, Shandong, China
      Shandong Cancer Hospital
    Mar 19, 2019